{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:23:21Z","timestamp":1740147801699,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"SGPGI","award":["PGI\/DIR\/RC\/607\/2016"],"award-info":[{"award-number":["PGI\/DIR\/RC\/607\/2016"]}]},{"DOI":"10.13039\/501100008758","name":"Council of Science and Technology, Uttar pradesh","doi-asserted-by":"crossref","award":["CST\/SEPRD\/D-5052"],"award-info":[{"award-number":["CST\/SEPRD\/D-5052"]}],"id":[{"id":"10.13039\/501100008758","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s12098-020-03183-5","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T15:04:29Z","timestamp":1587395069000},"page":"692-698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Steroid Responsiveness in Duchenne Muscular Dystrophy \u2013 Predictive Value of Epigenetic Regulator Histone Deacetylase 2"],"prefix":"10.1007","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3324-3626","authenticated-orcid":false,"given":"Sunil","family":"Pradhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Animesh","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kritika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durga Prassana","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"3183_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006340","volume":"6","author":"D Cheeran","year":"2017","unstructured":"Cheeran D, Khan S, Khera R, et al. Predictors of death in adults with Duchenne muscular dystrophy-associated cardiomyopathy. J Am Heart Assoc. 2017;6:e006340.","journal-title":"J Am Heart Assoc"},{"key":"3183_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s13311-018-00687-z","volume":"15","author":"PB Shieh","year":"2018","unstructured":"Shieh PB. Emerging strategies in the treatment of Duchenne muscular dystrophy. Neurotherapeutics. 2018;15:840\u20138.","journal-title":"Neurotherapeutics."},{"key":"3183_CR3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/S0140-6736(74)90071-3","volume":"304","author":"DB Drachman","year":"1974","unstructured":"Drachman DB, Toyka KV, Myer E. Prednisone in Duchenne muscular dystrophy. Lancet. 1974;304:1409\u201312.","journal-title":"Lancet."},{"key":"3183_CR4","volume":"5","author":"E Matthews","year":"2016","unstructured":"Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2016;5:CD003725.","journal-title":"Cochrane Database Syst Rev"},{"key":"3183_CR5","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1177\/08830738010160111406","volume":"16","author":"SD Johnsen","year":"2001","unstructured":"Johnsen SD. Prednisone therapy in Becker's muscular dystrophy. J Child Neurol. 2001;16:870\u20131.","journal-title":"J Child Neurol"},{"key":"3183_CR6","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00415-006-0212-1","volume":"253","author":"S Pradhan","year":"2006","unstructured":"Pradhan S, Ghosh D, Srivastava NK, et al. Prednisolone in Duchenne muscular dystrophy with imminent loss of ambulation. J Neurol. 2006;253:1309\u201316.","journal-title":"J Neurol"},{"key":"3183_CR7","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1038\/sj.onc.1204323","volume":"20","author":"FD Urnov","year":"2001","unstructured":"Urnov FD, Wolffe AP. Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene. 2001;20:2991\u20133006.","journal-title":"Oncogene."},{"key":"3183_CR8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","volume":"336","author":"PJ Barnes","year":"1997","unstructured":"Barnes PJ, Karin M. Nuclear factor-\u03baB \u2013 a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066\u201371.","journal-title":"N Engl J Med"},{"key":"3183_CR9","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1100\/tsw.2006.274","volume":"6","author":"K Ito","year":"2006","unstructured":"Ito K, Getting SJ, Charron CE. Mode of glucocorticoid actions in airway disease. Scientific World J. 2006;6:1750\u201369.","journal-title":"Scientific World J"},{"key":"3183_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1084\/jem.20050466","volume":"203","author":"K Ito","year":"2006","unstructured":"Ito K, Yamamura S, Essilfie-Quaye S, et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med. 2006;203:7\u201313.","journal-title":"J Exp Med"},{"key":"3183_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1513\/pats.200504-035SR","volume":"2","author":"IM Adcock","year":"2005","unstructured":"Adcock IM, Ito K. Glucocorticoid pathways in chronic obstructive pulmonary disease therapy. Proc Am Thorac Soc. 2005;2:313\u20139.","journal-title":"Proc Am Thorac Soc"},{"key":"3183_CR12","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1007\/s12098-016-2142-y","volume":"83","author":"HS Badr","year":"2016","unstructured":"Badr HS, El-Hawy MA, Helwa MA. P-glycoprotein activity in steroid-responsive vs. steroid-resistant nephrotic syndrome. Indian J Pediatr. 2016;83:1222\u20136.","journal-title":"Indian J Pediatr"},{"key":"3183_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3389\/fphar.2019.00558","volume":"10","author":"H Singh","year":"2019","unstructured":"Singh H, Agarwal V, Chaturvedi S, Misra DP, Jaiswal AK, Prasad N. Reciprocal relationship between HDAC2 and P-glycoprotein\/MRP-1 and their role in steroid resistance in childhood nephrotic syndrome. Front Pharmacol. 2019;10:558.","journal-title":"Front Pharmacol"},{"key":"3183_CR14","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1056\/NEJM198906153202405","volume":"320","author":"JR Mendell","year":"1989","unstructured":"Mendell JR, Moxley RT, Griggs RC, et al. Randomised double-blind six month trial of prednisone in Duchenne\u2019s muscular dystrophy. N Engl J Med. 1989;320:1592\u20137.","journal-title":"N Engl J Med"},{"key":"3183_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/archneur.1991.00530180027012","volume":"48","author":"GM Fenichel","year":"1991","unstructured":"Fenichel GM, Mendell JR, Moxley RT 3rd, et al. A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy. Arch Neurol. 1991;48:575\u20139.","journal-title":"Arch Neurol"},{"key":"3183_CR16","doi-asserted-by":"crossref","unstructured":"Griggs RC, Moxley RT 3rd, Mendell JR, et al; Clinical Investigation of Duchenne Dystrophy Group. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Arch Neurol. 1991;48:383\u20138.","DOI":"10.1001\/archneur.1991.00530160047012"},{"key":"3183_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0960-8966(98)00047-9","volume":"8","author":"AL Dubrovsky","year":"1998","unstructured":"Dubrovsky AL, Angelini C, Bonifati DM, Pegoraro E, Mesa L. Steroids in muscular dystrophy: where do we stand? Neuromuscul Disord. 1998;8:380\u20134.","journal-title":"Neuromuscul Disord"},{"key":"3183_CR18","doi-asserted-by":"crossref","unstructured":"DeSilva S, Drachman DB, Mellits D, Kuncl RW. Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit. Arch Neurol. 1987;44:818\u201322.","DOI":"10.1001\/archneur.1987.00520200022012"},{"key":"3183_CR19","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/jnnp.2005.078345","volume":"77","author":"DM Bonifati","year":"2006","unstructured":"Bonifati DM, Witchel SF, Ermani M, Hoffman EP, Angelini C, Pegoraro E. The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy. J Neurol Neurosurg Psychiatry. 2006;77:1177\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3183_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/ptj\/72.2.115","volume":"72","author":"JM Florence","year":"1992","unstructured":"Florence JM, Pandya S, King WM, et al. Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne\u2019s muscular dystrophy. Phys Ther. 1992;72:115\u201322.","journal-title":"Phys Ther"},{"key":"3183_CR21","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.4103\/0028-3886.241363","volume":"66","author":"H Arora","year":"2018","unstructured":"Arora H. Commonly available outcome measures for use in Indian boys with Duchenne muscular dystrophy. Neurol India. 2018;66:1279\u201385.","journal-title":"Neurol India"},{"key":"3183_CR22","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1073\/pnas.0712363105","volume":"105","author":"B Sahaf","year":"2008","unstructured":"Sahaf B, Atkuri K, Heydari K, et al. Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV disease. Proc Natl Acad Sci U S A. 2008;105:5111\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3183_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/15412550500346683","volume":"2","author":"IM Adcock","year":"2005","unstructured":"Adcock IM, Ito K, Barnes PJ. Histone deacetylation: an important mechanism in inflammatory lung diseases. COPD. 2005;2:445\u201355.","journal-title":"COPD."},{"key":"3183_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.nmd.2016.07.002","volume":"26","author":"P Bettica","year":"2016","unstructured":"Bettica P, Petrini S, D'Oria V, et al. Histological effects of givinostat in boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2016;26:643\u20139.","journal-title":"Neuromuscul Disord"},{"key":"3183_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2119\/molmed.2013.00011","volume":"19","author":"S Consalvi","year":"2013","unstructured":"Consalvi S, Mozzetta C, Bettica P, et al. Preclinical studies in the mdx mouse model of Duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat. Mol Med. 2013;19:79\u201387.","journal-title":"Mol Med"},{"key":"3183_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm1479","volume":"12","author":"GC Minetti","year":"2006","unstructured":"Minetti GC, Colussi C, Adami R, et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med. 2006;12:1147\u201350.","journal-title":"Nat Med"},{"key":"3183_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1084\/jem.20040416","volume":"200","author":"BG Cosio","year":"2004","unstructured":"Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med. 2004;200:689\u201395.","journal-title":"J Exp Med"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-020-03183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-020-03183-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-020-03183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:04:44Z","timestamp":1618877084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-020-03183-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["3183"],"URL":"https:\/\/doi.org\/10.1007\/s12098-020-03183-5","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"type":"print","value":"0019-5456"},{"type":"electronic","value":"0973-7693"}],"subject":[],"published":{"date-parts":[[2020,4,20]]},"assertion":[{"value":"13 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This work received support partially from Intramural Grant (PGI\/DIR\/RC\/607\/2016) of Sanjay Gandhi Post Graduate Institute of Medical Sciences, and partially from Council of Science and Technology grant, Uttar Pradesh, India (CST\/SEPRD\/D-5052).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Source of\u00a0Funding"}}]}}